Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A broad classification of dysgammaglobulinemias characterized by low or undetectable serum levels of immunoglobulin class G (IgG). Deficiencies of IgG present variably according to subclass. IgG deficiencies are typically relative among subclasses and not absolute. Thus even with a given selective IgG subclass deficiency, total IgG levels may still fall within normal range. The clinical course and prognosis is dependent upon the severity of the deficiency and associated morbidity.
Biomarker and diagnostic research for selective IgG immunodeficiency has been reported in the published literature.
No clinical trials have been registered for selective IgG immunodeficiency.
227 publications have been identified in PubMed for selective IgG immunodeficiency. Research spans Basic Science / Preclinical (30%), Epidemiology / Natural History (19%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 67 | 30% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 7:47 AM UTC
Disease patterns and progression
42 |
19% |
Research summaries | 41 | 18% |
Patient case studies | 37 | 16% |
Clinical study results | 24 | 11% |
Testing and diagnosis research | 9 | 4% |
New treatment approaches | 6 | 3% |
Other research | 1 | 0% |
Xu Y (2026). [PMID: 41435605](https://pubmed.ncbi.nlm.nih.gov/41435605/). *Phytomedicine : international journal of phytotherapy and phytopharmacology*. [Basic Science / Preclinical]
Dogru Y (2026). [PMID: 41869311](https://pubmed.ncbi.nlm.nih.gov/41869311/). *Front Immunol*. [Basic Science / Preclinical]
Elmoursi A (2026). [PMID: 42250902](https://pubmed.ncbi.nlm.nih.gov/42250902/). *J Allergy Clin Immunol Pract*. [Review / Meta-Analysis]
Elwy A (2026). [PMID: 41697746](https://pubmed.ncbi.nlm.nih.gov/41697746/). *J Clin Invest*. [Basic Science / Preclinical]
Fetta A (2026). [PMID: 41406406](https://pubmed.ncbi.nlm.nih.gov/41406406/). *Neurol Neuroimmunol Neuroinflamm*. [Review / Meta-Analysis]
Yang Y (2026). [PMID: 42199414](https://pubmed.ncbi.nlm.nih.gov/42199414/). *Front Immunol*. [Basic Science / Preclinical]
Xia W (2026). [PMID: 42113501](https://pubmed.ncbi.nlm.nih.gov/42113501/). *Iran J Allergy Asthma Immunol*. [Case Report / Case Series]
Montgomery RA (2026). [PMID: 41233546](https://pubmed.ncbi.nlm.nih.gov/41233546/). *Nature*. [Basic Science / Preclinical]
Cui T (2026). [PMID: 41671178](https://pubmed.ncbi.nlm.nih.gov/41671178/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Khalaf L (2026). [PMID: 41618198](https://pubmed.ncbi.nlm.nih.gov/41618198/). *BMC Pediatr*. [Case Report / Case Series]